T. Rowe Price Associates’s AN2 Therapeutics ANTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-187,399
Closed -$3.84M 2957
2023
Q4
$3.84M Buy
+187,399
New +$3.84M ﹤0.01% 1287